chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately after vaccine patient said he felt funny and then fainted. It lasted about 30 seconds. As he was recovering the patient started to have a seizure. Seizure lasted 30 to 45 seconds. Pharmacy called 911. Paramedics checked vitals and child was released to go home. (Patient caregiver answered NO on the form regarding fainting & seizures, however while waiting for paramedics the caregiver told pharmacist that he does have a history of fainting & seizures, but she was not aware of the extent)
Information has been received from a licensed practical nurse concerning about 5 or 6 patients who on approximately 24-SEP-2007 about a month ago, were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the patients experienced a sore arm, swelling and redness around the injection site. Unspecified medical attention was sought. It is unknown if laboratory diagnostic studies were performed. At the time of this report, the patients outcomes were unknown. No product quality complaint was involved. This is one of two reports from the same source. Additional information has been requested.
Bad cough; Runny Nose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Bad cough) and RHINORRHOEA (Runny Nose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced COUGH (Bad cough) and RHINORRHOEA (Runny Nose). At the time of the report, COUGH (Bad cough) and RHINORRHOEA (Runny Nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported.
This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea consistently everyday), DIARRHOEA (diarrhea) and CONDITION AGGRAVATED (bones continue to ache more after vax, different areas) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 013L20A) for COVID-19 vaccination.    Co-suspect product included non-company product MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    Concurrent medical conditions included Arthritis (more pain in bones) since 1985, Hypothyroidism (underactive thyroid) since 1985, Glaucoma (MILD) since 2010, Blood pressure high (MODERATE HBP) since 1985, Drug allergy (LEVOTHYROXINE) and Drug allergy (PREMARIN). Concomitant products included DICLOFENAC SODIUM, LINUM USITATISSIMUM, MENTHOL, METHYL SALICYLATE, THIOCOLCHICOSIDE (INSTAFLEX) for Arthritis, TRAVOPROST (TRAVATAN Z) and TIMOLOL for Glaucoma, LISINOPRIL for Hypertension, NAPROXEN SODIUM (ALEVE) and ACETAMINOPHEN for Pain, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroiditis, PROBIOTICS NOS for Urinary tract disorder.   On 14-Jan-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started MULTIVITAMIN [VITAMINS NOS] (Oral) 1 dosage form. On 24-Mar-2021, the patient experienced DIARRHOEA (Diarrhea consistently everyday). On 29-Jun-2021, the patient experienced DIARRHOEA (diarrhea). On an unknown date, the patient experienced CONDITION AGGRAVATED (bones continue to ache more after vax, different areas). The patient was treated with PLANTAGO OVATA (METAMUCIL [PLANTAGO OVATA]) ongoing since an unknown date for Diarrhoea, at an unspecified dose and frequency. On 29-Mar-2021, DIARRHOEA (Diarrhea consistently everyday) had resolved. At the time of the report, DIARRHOEA (diarrhea) and CONDITION AGGRAVATED (bones continue to ache more after vax, different areas) outcome was unknown.            Concomitant medication included probiotic for urinary tract health and digestive health.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15 july 2021.concomitant information updated, new event added.
C/o chills, cold sweats, difficulty sleeping and nausea approx 6-8 hrs after receiving immunization, 24 hrs later fatigue, cont. nausea.
She has been experiencing intermittent back, shoulder, and arm pain; She has been experiencing intermittent back, shoulder, and arm pain; She has been experiencing intermittent back, shoulder, and arm pain; This is a spontaneous report from a Pfizer sponsored program support. A contactable 69-year-old female consumer (patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number; NDC number: unknown, Expiration Date: unknown), via an unspecified route of ad-ministration, administered in arm left on 24May2021 as single dose for covid-19 immunisation. Medical history included diabetic, hypertension (diagnosed when she was 55), stage 1 breast cancer from Jun2017 (she had a mastectomy on 22Aug2017), patient was allergic to sulfa and penicillin, patient was immunocompromised. The patient previously took anastrozole for the past 4 years (1mg every night) for breast cancer and still ongoing. The patient was taking smarty pants vitamin for women for a year and a half which contains vitamin a, c, d, e, k, thiamine, B3, B6, B12, and biotin. Concomitant medication included pravastatin taken for blood cholesterol as 20 mg, hydralazine 50 mg, 2x/day, metformin 850 mg, 2x/day, lisinopril 10 mg, daily and glipizide ER as 10mg daily with breakfast. There was investigation assessment. The patient experienced a side effect 24 hours after the first dose of the Pfizer covid vaccine which she received on 24May2021. Since the vaccine, the patient had experienced back pain, shoulder pain, and arm pain on and off. She was supposed to go back to work but because of this pain she was able too. The patient was immunocompromised and takes anastrozole. She had a history of stage 1 breast cancer and had a mastectomy. This morning (27May2021), the patient woke up at about 1:00 am and her back and arms were aching. The back pain, shoulder pain, and arm pain all started on 25May2021. She later clarifies and confirmed that the back pain, shoulder pain, and arm pain all began on 26May2021. She wants to make sure that nothing will happen to her. She had to take the second dose of the Pfizer covid vaccine on 15Jun2021. Sometimes the patient has back pain when she was really tired at work, prior to the vaccine. The back pain that the patient was experiencing after the vaccine goes away for about 2 hours and then it comes back, she knows it will come back. Right now, her pain was gone. The patient lab tests included cholesterol was kind of high on her most recent blood work. The patient took one Tylenol yesterday, 26May2021. The outcome of the events was not resolved.  Information about batch/Lot number has been requested.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.
Pt had rash come up on both lower arms and pain that "felt like it went to bones" lasted for a few days.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received SHINGRIX for prophylaxis. On 2nd March 2019, the patient received the 1st dose of SHINGRIX. On 2nd March 2019, several hours after receiving SHINGRIX, the patient experienced pain in arm, injected limb mobility decreased and sleeplessness. On an unknown date, the outcome of the pain in arm was not recovered/not resolved and the outcome of the injected limb mobility decreased and sleeplessness were recovered/resolved. It was unknown if the reporter considered the pain in arm, injected limb mobility decreased and sleeplessness to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The caller reported she got SHINGRIX on Saturday. After a few hours her arm started throbbing and she could not move it. The pain kept her up all Saturday night and she could not move her arm on Sunday. The patient can now move her arm again, but it still throbs. The pain was in her whole upper arm, not just at the injection site. The caller declined to provide any information other than her first name.
Began vomiting 1 hour post vax, 24 hours later temp to 101.5
Patient has had menses since that first vaccine and it has not stopped to date of this report (2 months). Prior to this, had menses q1-4 months over the past year, lasting 7 days. No other changes other then vaccine. I did order labs today to further investigate.
Patient was 16 years old when given Moderna vaccine.  No reports of any adverse effects; as of today (4/20/21).
After I receive my flu shot I noticed that I started stuttering only for a few hours on October 19, October 22, October 26, and out October 28 I was hospitalized thought I was having mini strokes because the stuttering just got worse along with a stiff neck also where they injected the shot on my left arm everything on my left hand side from my left leg my left arm I had a left pain in my neck I only had pain in my left ear my whole left side of my head.
Very painful shot with extreme pain in shot area of arm for 48+ hours. Pain has since turned into 24/7  achy/burning sensation in same area. It has not subsided and use of left arm is painful and restricted. Does not respond to pain relievers such as alleve or ibuprofen.
Bruises on the legs; Itching all over body; Numbness on hands, arms, legs, and toes; Heartbeat Palpitations; Heartbeat Palpitations; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 25Aug2021 at 12:30 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 05Sep2021, the patient had bruises on the legs, numbness on hands, arms, legs and toes, itching all over body and heartbeat palpitations. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with methylprednisolone (MANUFACTURER UNKNOWN). Since the vaccination, the patient had been tested for COVID-19. On 10Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the events bruises on the legs, numbness on hands, arms, legs and toes, itching all over body and heartbeat palpitations were resolving at the time of this report.
soreness at injection site for first few days then a week later red and swelling along with severe itching.   Benadryl cream helped itching a little
Information has been received from a physician concerning a male patient who, at 4 years old, was vaccinated with a dose of varicella virus vaccine live.  Subsequently, at 7 years old, the patient developed 200 chickenpox lesions.  Unspecified medical attention was sought.  No product quality complaint was involved.  Additional information has been requested.
Aches all over, sore throat, headache, lethargy, chills, fever
Started breaking out 1/19. Itches - rash. No known exposure. No fever. DX: Varicella
Sore joints, swelling in joints, stiffness. Diagnosed with Lyme disease. Follow up 01/27/05: Patient still has soreness, swelling and pain in joints.
On 10/29/02 @ approximately 11:30 hrs, pt awoke with "pain in his entire lower back. At approximately 17:00, the same day (10/24/02), pt states his pain was transferred to left kidney area. Pt states pain has been constant and is still currently there.
Did not receive full dose of first vaccine; A spontaneous report  was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and did not receive a full dose of her first Vaccine.    The patient's medical history was not provided.  Concomitant product use was not provided.  On 22 Jan 2021, the patient received their first of two planned doses of mRNA-1273, (Batch number not provided) intramuscularly for prophylaxis of COVID-19 infection.   On 22 Jan 2021, the patient reported that she did not received full dose.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.  The event was considered resolved on 22 Jan 2021.; Reporter's Comments: This report refers to a case of Incorrect dose administered for mRNA-1273 with no associated AEs.
Pt stated that after she received the COVID-19 vax she had pain in her left arm. She started having swelling, redness, chills, muscle aches, pains, fever (99.3), SOB, and fatigue. Her SOB is requiring her use more O2 than normal. Today she still has swelling, redness and soreness around the injection site that is worse than on the first day. Her PCP came to see her yesterday on 3/2/2021 and they told her that her symptoms meant that her immune system was working.  Care giver would recommend her to go to the ER if her symptoms persisted.
About 4x3 inch red, swollen and hot area below where DTAP given (left arm), irritable, fever 100.3.
On 04/13/2000 post-vax, the patient developed a local reaction of 5cm of swelling. A physician evaluated the patient. From correspondence received from Aventis Pasteur on 05/02/2000, additional patient, vaccine and responsible physician information was provided.
Fever to 101.5, nausea, dizziness, myalgias, and headache.
Information has been received from a health professional concerning an 8 year old female with no medical history and no known allergies who on 05-SEP-2007, received her second dose of varicella virus vaccine live (Oka/Merck) (lot # 658018/1007U) 0.5 mL subcutaneously in the outer aspect of the left upper arm. Concomitant vaccine included Havrix. On 07-SEP-2007, she returned to the office for evaluation of the outer aspect of the upper left arm (site of varicella virus vaccine live (Oka/Merck) administration) that was red, swollen and blistered. Diagnostics included a culture of the blister that revealed no significant findings. Treatment included: a prescription for Keflex of 5 days duration and a "dry dressing". On 10-SEP-2007, the patient's mother called the physician's office to report a new blister. Patient's current status was not reported. A product quality complaint was not reported. No further information was available. Additional information has been requested.
Elevated Liver Enzymes found upon routine bloodwork for wellness check up with Dr. When retested to in December to confirm numbers have normalised, numbers have almost tripled. Since 12/1, I have had complete workup around liver function, possible infections, antibody and genetic testing and all have ruled out any other cause. Ultrasound is normal and I have felt well throughout. I have abstained from alcohol of any kind since 11/10/22 before the retest of the blood per doctors orders.
Patient was 17 years had the first dose of vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient was 17 years had the first dose of vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient was 17 years had the first dose of vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient was 17 years had the first dose of vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment provided.  No concomitant medications were provided.
Pt had tennis ball sized area of redness with induration on the left thigh where the vaccine was administered.
This spontaneous report was received from a registered nurse refers to an 18 year old female patient. No pertinent medical history was reported. On 29-JUN-2015, the patient was inadvertently vaccinated with a dose of VARIVAX (Merck) (dose and lot# were not reported) subcutaneous which had been inadvertently reconstituted with a dose of MENACTRA instead of Sterile Water Diluent. On 29-JUN-2015, the patient experienced injection site discomfort and injection site erythema immediately following administration, while still in the physician's office. No treatment was given to the patient. No Product Quality Complaint (PQC) was involved. Action taken was not applicable. The outcome of events was unknown. The reporter did not provide the causality between the event and the suspect therapy. Additional information has been requested.
My Mom went from being able to walk fine on her own to suddenly being confined to a wheelchair because she could not walk after the 2nd vaccine. She was lethargic, weak, sleepy & in excruciating nerve pain throughout her body.  Her doctors office said to let her get plenty of rest, fluids, & to take Tylenol for pain. She had previously had only mild cognitive impairment, which seems to have become accelerated & she is much more confused. Because she was sleeping & not eating & drinking enough, she then became dehydrated. She was then admitted to the Emergency Room Hospital
12JUN91, call from mom states on 7JUN91 4 hrs p/DTP pt turned very pale, limp, & was not responsive to voice; lasted 2-3 min; Admitted to Hosp same day for observation;
Hives after intradermal flu vaccine. Relieved with OTC ZYRTEC.
less than 18 year-old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (less than 18 year-old) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (less than 18 year-old). On 19-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (less than 18 year-old) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to event was not applicable.
She had vomiting but with no raise at site of injection(left deltoid) but she said it was the size of a thumb print and she had muscle tightness in the area. She also had cold and flu like symptoms: fever, aches, chills.
Patient received first dose of Moderna COVID-19 vaccine on 3/27/2021. She complained of "thickening in her throat" and lips tingling. She was evaluated by doctor and another doctor. She was given Benadryl. EMS also gave nebulized albuterol x1. Patient observed for 30 min and sent home. Recommend patient get second dose in monitored setting
She tested positive for COVID 2 weeks post vaccination; She tested positive for COVID 2 weeks post vaccination; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported) via an unspecified route of administration on 22Jan2021 as DOSE 1 ,SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that she tested positive for covid 2 weeks post vaccination on an unspecified date in 2021 ,patient said that She never received her second dose. She was tested positive for COVID 2 weeks post vaccination and she wanted to know whether she can receive the second dose or should she had restart the vaccination response received was vaccination of people with SARS-CoV-2 infection should be differed until the person had recovered from the acute illness suggested that the risk of SARS-CoV-2 reinfection was low in the months after initial infection but might increase with time due to warning immunity patient was tested positive after vaccine, second dose beyond 21 days. CEP 159558. The patient underwent lab tests and procedures which included sars-cov-2 test positive on 2021. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the known safety profile and a positive temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported Covid-19.
Symptoms:Moderate pain & redness at injection site; tiredness, muscle pain, headache and shivering. Discomfort sufficient to prevent normal activities.  Treatment: Rest, Ibuproferin Outcome: Recovery after 36+ hours
Information has been received from a physician concerning a patient who was vaccinated with varicella virus vaccine live. The physician reported that the patient developed approximately 50 lesions, two weeks after receiving varicella virus vaccine live. The physician reported he did not recall who the patient was, therefore no other information was available regarding the adverse event or the patients outcome. There was no product quality complaint reported. The patient sought unspecified medical attention. No additional information is expected.